Alcoholic neuropathy and remedies
DOI:
https://doi.org/10.56511/JIPBS.2016.v3.i02.pp66-70Abstract
Neuropathy is caused by a wide variety of factors, however majority of them are under reported till date. Medicinal plants have been used in research long before the centuries to extract out the therapeutic effect in order to relieve the morbidities. The administration of alcohol for long time causes the advent of alcoholic neuropathic like state. Herbal drugs offer a novel approach in the treatment of the disorder. Thus, further exploration is needed in order to explore the further mechanism that will provide substantial support for claiming the therapeutic effect.
Keywords:
neuropathy, chronic, alcoholism, remedies, immunityDownloads
References
Dina O.A, Khasar S.G, Alessandri-Haber N, Green P.G, Messing R.O and Levine J.D: Alcohol-induced stress in painful alcoholic neuropathy Eur. J. Neurosci 2008; 27, 8392.
Watkins L.R, Milligan E.D and Maier S.F. Spinal cord glia: new players in pain, Pain 2001; 93, 201-5.
Norenberg N.D. Astrocyte responses to CNS injury, J. Neuropathol. Exp. Neurol. 1994; 53, 213-20.
Narita M, Miyoshi K, Narita M. and Suzuki T: Involvement of microglia in the ethanolinduced neuropathic pain-like state in the rat, Neurosci. Lett. 2007; 414:21-5.
Weir D.G. and Scott J.M: The biochemical basis of the neuropathy in cobalamin deficiency, BaillieresClin. Haematol 1995; 8:479-97.
Netzel M, Ziems M, Jung K.H, Noll E, Borsch C. and Bitsch I: Effect of high-dosed thiamine hydrochloride and Sbenzoylthiamine-O-monophosphate on thiamine-status after chronic ethanol administration , Biofactors 2000; 11:1113.
Narita M, Miyoshi K, Narita M. and Suzuki T: Involvement of microglia in the ethanolinduced neuropathic painlike state in the rat, Neurosci. Lett, 2007; 414: 21-5.
Weir D.G. and Scott J.M: The biochemical basis of the neuropathy in cobalamin deficiency, BaillieresClin. Haematol 1995; 8:479-97.
Netzel M, Ziems M, Jung K.H, Noll E, Borsch C. and Bitsch I: Effect of high-dosed thiamine hydrochloride and Sbenzoylthiamine-O-monophosphate on thiamine-status after chronic ethanol administration, Biofactors 2000;11: 111-3.
Nagamatsu M, Nickander K.K., Schmelzer J.D., Raya A., WittrockD.A., Tritschler H. and Low P.A: Lipoic acid improves blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy, Diabetes Care 1995; 18:1160-67.
Maestri A, De Pasquale Ceratti A, Cundari S, Zanna C, Cortesi E. and Crino L: A pilot study on the effect of acetyl-L-carnitine in paclitaxeland cisplatin-induced peripheral neuropathy, Tumori, 2005;91,135-38.
Tiwari V., Kuhad A. and Chopra K: Tocotrienol ameliorate behavioral and biochemical alterations in the rat model of alcoholic neuropathy, Pain 2009; 145:12935.
Nickander K.K, Schmelzer J.D, Rohwer D.A. and Low P.A: Effect of alpha-tocopherol deficiency on indices of oxidative stress in normal and diabetic peripheral nerve, J. Neurol. Sci. 1994; 126:6-14.
Shy M.E. Peripheral neuropathies. In: Goldman L., Ausiello D., eds. Cecil Medicine. rd 23 ed. Philadelphia, Pa: Saunders Elsevier; 2007: chap 446.
Harati Y. and Bosch E.P. Disorders of peripheral nerves. In: Bradley W.G., Daroff R.B., Fenichel G.M. and Jankovic J., eds. th Bradley: Neurology in Clinical Practice. 5 ed. Philadelphia, Pa: ButterworthHeinemann Elsevier; 2008: chap 80.
Love A, Cotter M.A. and Cameron N.E: Effects of the sulphydryl donor N-acetyl-Lcysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic rats, Eur. J. Clin. Invest 1996; 26:698-706.
Rains C. and Bryson H.M: Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis 1995; 7:317-28.
Finnerup N.B, Otto M, McQuay H.J, Jensen T.S. and Sindrup S.H: Algorithm for neuropathic pain treatment: an evidence based proposal Pain, 2005; 118:289-305.
Sandercock D, Cramer M, Wu J, Chiang Y.K, Biton V. and Heritier M: Gabapentin extended release for the treatment of painful diabetic peripheral neuropathy: efficacy and tolerability in a double-blind, randomized, controlled clinical trial Diabetes Care 2009; 32, e20.
Mawdsley C. and Mayer R.F. Nerve Conduction in Alcoholic Polyneuropathy, Brain; a journal of neurology 1965; 88(2):335-356.
Vittadini G, Buonocore M, Colli G, Terzi M, Fonte R. and Biscaldi G. Alcoholic Polyneuropathy: A Clinical and Epidemiological Study, Oxford Journals 2001; 36(5):393-400.
Sun Y, Lai M.S. and Lu C.J: Effectiveness of vitamin B12 on diabetic neuropathy: systematic review of clinical controlled trials ,ActaNeurol Taiwan 2005; 14:48-54.
Sundkvist G, Dahlin LB, Nilsson H, Eriksson K.F., Lindgarde F, Rosen I., Lattimer S.A., Sima A.A., Sullivan K. and Greene D.A: Sorbitol and myo-inositol levels and morphology of sural nerve in relation to peripheral nerve function and clinical neuropathy in men with diabetic, impaired, and normal glucose tolerance, Diabet. Med. 2000; 17:259-68.
Glynn P. Neural development and neurodegeneration: two faces of neuropathy target esterase, Prof. Neurobiol 2000; 61(1):61-74.
Published
How to Cite
Issue
Section
Copyright (c) 2016 Shashidhar Mehta, Puneet Sudan, Shaveta Bhardwaj, Sonika Redhu Sihag, Rajesh Kumar Pandey
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at